<DOC>
	<DOCNO>NCT01286311</DOCNO>
	<brief_summary>The primary goal trial test feasibility efficacy cardiovascular disease quality improvement system couple EMR-based patient identification individually tailor patient message . The study test hypothesis tailor patient-directed approach cardiovascular risk reduction integrate patient ' primary care delivery site improve control elevate low-density lipoprotein cholesterol card iac risk factor routine care alone patient intermediate high risk cardiovascular disease .</brief_summary>
	<brief_title>Tailored Communication Reduce Cardiovascular Risk</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Age 40 79 year medication list include active lipid lower medication patient diagnosis past medical history , active problem list past visit encounter coronary heart disease , heart failure , stroke , diabetes mellitus , peripheral arterial disease patient enrol study physician record his/her primary care physician patient LDL cholesterol meet one criterion list . LDL cholesterol &gt; = 130 mg/dl estimate Framingham Risk Score 1020 % LDL cholesterol &gt; = 100 mg/dl estimate Framingham Risk Score &gt; 20 % LDL cholesterol &gt; = 160 mg/dl estimate Framingham Risk Score 5 % &lt; 10 % . Age &lt; 40 &gt; 79 year medication list include active lipid lower medication patient hase diagnosis past medical history , active problem list past visit encounter coronary heart disease , heart failure , stroke , diabetes mellitus , peripheral arterial disease patient enrol study physician record his/her primary care physician patient LDL cholesterol meet one criterion list . LDL cholesterol &gt; = 130 mg/dl estimate Framingham Risk Score 1020 % LDL cholesterol &gt; = 100 mg/dl estimate Framingham Risk Score &gt; 20 % LDL cholesterol &gt; = 160 mg/dl estimate Framingham Risk Score 5 % &lt; 10 % .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Health Education</keyword>
	<keyword>Health Knowledge , Attitudes , Practice</keyword>
	<keyword>Hypolipidemic Agents/therapeutic use</keyword>
	<keyword>Patient Education Topic</keyword>
</DOC>